- DHL extends its global Life Sciences & Healthcare network in key emerging market
- Warehousing, distribution and clinical trial services for the pharmaceutical and medical devices industry provided in 56,000 sqm multi-customer warehouse
- Use of green technology
Bonn, 06/14/2012, 11:00 AM CEST – The new distribution center will offer a complete portfolio of innovative services to manufacturers of pharmaceutical products.
DHL Supply Chain, the global market leader for contract logistics solutions, today announced the opening of a new distribution center for the Life Sciences & Healthcare industry in Mumbai, India. This first state-of-the-art Life Sciences facility is located within a newly constructed 56.000 square meter multi-customer distribution center and will cater to the requirements of the rapidly growing Life Sciences industry in one of the most important emerging Life Sciences & Healthcare markets in the world.
“The new platform in Mumbai will enable us to provide a world class service to our customers, enabling them to expand their businesses. Life Sciences & Healthcare is a key industry for DHL Supply Chain in India. By setting up this world class infrastructure we continue to meet the industry’s increasing logistics and warehousing needs. We have the capabilities to distribute to wholesalers, pharmacists and hospitals from our new center in Mumbai based on customer demands,” said Vikas Anand, Chief Operating Officer, DHL Supply Chain India.
From order management to warehousing & distribution
The new DHL Supply Chain Life Sciences & Healthcare distribution center will offer a complete portfolio of innovative services to manufacturers of pharmaceutical products from order management to warehousing & distribution. DHL’s services are customized to the needs of the medical devices and pharmaceutical industry, including very specific solutions such as postponement services, clinical trials logistics and order-to-cash. The Multi-Client Site uses green technology such as LED lighting and wind assisted ventilation.
“DHL is strongly committed to investing in markets of growing importance. Looking to 2015 and beyond, India, China and other emerging markets are expected to be the key drivers of growth in the pharmaceutical and medical device sectors. With this warehouse, we take another step in pursuing DHL’s global industry sector strategy by opening our new platform and deliver exactly the specialized services that our clients are asking for”, said Angelos Orfanos, President and Global Head of Life Sciences & Healthcare, DHL Customer Solutions & Innovation.
Global Life Sciences & Healthcare strategy
DHL operates over 150 Life Sciences facilities worldwide to support its global Life Sciences & Healthcare strategy. This provides the platform to offer sector specific solutions. The pharmaceuticals market was valued at EUR730bn in 2010 and is projected to grow by 5-8% until 2015. Similar growth rates apply for medical devices, with a total market size of EUR200bn. The emerging markets are forecasted to contribute approx. 75 per cent of global pharmaceutical sales growth by 2015. According to IMS Research, India’s rank as a pharmaceutical market is expected to increase from 2010 to 2015 – from 12th to 8th place; the market’s share of US pharmaceutical spend is also expected to grow from 4% to 8% over the same period.
